Unique aspects of anti-cancer drug development / / edited by Jolanta Natalia Latosińska, Magdalena Latosińska.

The evidence of cancer in humans, animals and plant species suggests that it is as old as multicellular life on Earth. Why is it so difficult to understand and fight? Because cancer begins from the organism's own mutated single cell focused on its own survival. It would be naive to expect that...

Full description

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Place / Publishing House:[Place of publication not identified] : : IntechOpen,, [2017]
©2017
Year of Publication:2017
Language:English
Physical Description:1 online resource (146 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993546835604498
ctrlnum (CKB)4100000001586790
(NjHacI)994100000001586790
(oapen)https://directory.doabooks.org/handle/20.500.12854/61614
(EXLCZ)994100000001586790
collection bib_alma
record_format marc
spelling Jolanta Natalia Latosinska auth
Unique aspects of anti-cancer drug development / edited by Jolanta Natalia Latosińska, Magdalena Latosińska.
IntechOpen 2017
[Place of publication not identified] : IntechOpen, [2017]
©2017
1 online resource (146 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on print version record.
The evidence of cancer in humans, animals and plant species suggests that it is as old as multicellular life on Earth. Why is it so difficult to understand and fight? Because cancer begins from the organism's own mutated single cell focused on its own survival. It would be naive to expect that cancer could be ever entirely eliminated, but there is still hope for finding effective treatments. The book is to give a view of selected aspects of cancer like its spread in nature, novel anticancer drugs based on Chinese herbs or birch bark, novel promising targets of annexins and kinases and progress in immunotherapy. It is our hope that you will find in this book interesting, inspiring and stimulating information concerning cancer research.
English
Tumors.
Oncology.
Medicine
Chronooncology
Oncology
Health Sciences
953-51-3347-0
Latosińska, Magdalena, editor.
Latosińska, Jolanta Natalia, editor.
language English
format eBook
author Jolanta Natalia Latosinska
spellingShingle Jolanta Natalia Latosinska
Unique aspects of anti-cancer drug development /
author_facet Jolanta Natalia Latosinska
Latosińska, Magdalena,
Latosińska, Jolanta Natalia,
author_variant j n l jnl
author2 Latosińska, Magdalena,
Latosińska, Jolanta Natalia,
author2_variant m l ml
j n l jn jnl
author2_role TeilnehmendeR
TeilnehmendeR
author_sort Jolanta Natalia Latosinska
title Unique aspects of anti-cancer drug development /
title_full Unique aspects of anti-cancer drug development / edited by Jolanta Natalia Latosińska, Magdalena Latosińska.
title_fullStr Unique aspects of anti-cancer drug development / edited by Jolanta Natalia Latosińska, Magdalena Latosińska.
title_full_unstemmed Unique aspects of anti-cancer drug development / edited by Jolanta Natalia Latosińska, Magdalena Latosińska.
title_auth Unique aspects of anti-cancer drug development /
title_new Unique aspects of anti-cancer drug development /
title_sort unique aspects of anti-cancer drug development /
publisher IntechOpen
IntechOpen,
publishDate 2017
physical 1 online resource (146 pages)
isbn 953-51-4739-0
953-51-3348-9
953-51-3347-0
callnumber-first R - Medicine
callnumber-subject RD - Surgery
callnumber-label RD651
callnumber-sort RD 3651 U557 42017
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.994
dewey-sort 3616.994
dewey-raw 616.994
dewey-search 616.994
work_keys_str_mv AT jolantanatalialatosinska uniqueaspectsofanticancerdrugdevelopment
AT latosinskamagdalena uniqueaspectsofanticancerdrugdevelopment
AT latosinskajolantanatalia uniqueaspectsofanticancerdrugdevelopment
status_str n
ids_txt_mv (CKB)4100000001586790
(NjHacI)994100000001586790
(oapen)https://directory.doabooks.org/handle/20.500.12854/61614
(EXLCZ)994100000001586790
carrierType_str_mv cr
is_hierarchy_title Unique aspects of anti-cancer drug development /
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1796648768647462912
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01062nam a2200325 i 4500</leader><controlfield tag="001">993546835604498</controlfield><controlfield tag="005">20221007185603.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221007s2017 xx o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-4739-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-3348-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000001586790</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994100000001586790</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/61614</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000001586790</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RD651</subfield><subfield code="b">.U557 2017</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Jolanta Natalia Latosinska</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Unique aspects of anti-cancer drug development /</subfield><subfield code="c">edited by Jolanta Natalia Latosińska, Magdalena Latosińska.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2017</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Place of publication not identified] :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">[2017]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (146 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on print version record.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The evidence of cancer in humans, animals and plant species suggests that it is as old as multicellular life on Earth. Why is it so difficult to understand and fight? Because cancer begins from the organism's own mutated single cell focused on its own survival. It would be naive to expect that cancer could be ever entirely eliminated, but there is still hope for finding effective treatments. The book is to give a view of selected aspects of cancer like its spread in nature, novel anticancer drugs based on Chinese herbs or birch bark, novel promising targets of annexins and kinases and progress in immunotherapy. It is our hope that you will find in this book interesting, inspiring and stimulating information concerning cancer research.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Tumors.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Oncology.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Chronooncology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Oncology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health Sciences</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-51-3347-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Latosińska, Magdalena,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Latosińska, Jolanta Natalia,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 21:09:21 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2018-01-13 17:16:47 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5351649280004498&amp;Force_direct=true</subfield><subfield code="Z">5351649280004498</subfield><subfield code="b">Available</subfield><subfield code="8">5351649280004498</subfield></datafield></record></collection>